ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can new drugs delay inherited Alzheimer's? major trial underway
Disease control OngoingThis study tests whether certain drugs can slow down memory and thinking problems in people who have a genetic form of Alzheimer's disease. About 490 adults aged 18-80 with a known Alzheimer's-causing gene mutation are taking part. Researchers measure changes in thinking skills a…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Gum treatment may slow Alzheimer's, new study hopes to prove
Disease control ENROLLING_BY_INVITATIONThis study looks at whether treating severe gum disease can slow down Alzheimer's disease. Researchers think that gum infections cause body-wide inflammation, which may worsen Alzheimer's. 26 people with both conditions will get gum treatment and be followed for 2 years with memo…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New Alzheimer's drug aims to clear brain plaques in Early-Stage patients
Disease control OngoingThis study tests an experimental drug called RO7126209 in people with early or mild-to-moderate Alzheimer's disease who have amyloid plaques in their brain. The main goals are to check the drug's safety and see if it can reduce amyloid buildup. About 241 participants will receive…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Could a drug combo delay genetic Alzheimer's?
Disease control OngoingThis study tests whether a new drug, E2814, given alongside lecanemab, can slow the progression of Alzheimer's disease in people who carry a genetic mutation that causes the disease. About 197 adults aged 18-80 with mild symptoms or no symptoms will receive either the drug or a p…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Blood test aims to cut Alzheimer's diagnosis time
Diagnosis TerminatedThis study looked at whether a blood test called PrecivityAD2 could help doctors diagnose Alzheimer's disease faster in people with memory problems. Participants were to be randomly assigned to get the test results early or later. The goal was to see if early testing shortens the…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Diagnosis
Last updated Jun 15, 2026 19:04 UTC